Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Romina Rose Pedone
Observed names:
R.R. Pedone,
Romina R. PEDONE
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0001-5159-5604
Observed ORCID:
0000-0001-5159-5604
OpenAlex ID:
A5013332860
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients
2023
·
Ernesto Rossi
, Francesco Cellini
, et al.
·
Cancers
·
9
PDF
Pattern of disease recurrence and outcomes after progression of high-risk renal cell carcinoma (RCC) patients treated with adjuvant immunotherapy
2026
·
Chiara Ciccarese
, Denis Occhipinti
, et al.
·
Cancer Immunology Immunotherapy
·
4
PDF
The Impact of Uncommon HRR Alterations as Predictors of Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials
2025
·
Giada Pinterpe
, Fortuna Migliaccio
, et al.
·
Targeted Oncology
·
3
The role of circulating kidney injury molecule-1 (KIM-1) in metastatic renal cell carcinoma (mRCC): A biomarker analysis of Tide-A, a phase 2 study of first-line avelumab (ave) plus intermittent axitinib (axi).
2025
·
Chiara Ciccarese
, Antonio Agostini
, et al.
·
Journal of Clinical Oncology
·
3
PDF
The Clinical Role of Hypoxia Inducible Factor (HIF) Inhibition in Renal Cancer: A Focus on Belzutifan
2025
·
Daniela Arduini
, Chiara Ciccarese
, et al.
·
Current Cancer Drug Targets
·
3
A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients
2024
·
Marilena la Sorda
, Desy De Lorenzis
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
A phase II study of nivolumab plus metformin in pre-treated metastatic renal cell carcinoma patients: NivoMet TWINS-GU002 Study
2025
·
Chiara Ciccarese
, Daniela Arduini
, et al.
·
Tumori Journal
·
2
Clinical and technical insights on KIM-1: what we need to know
2026
·
Daniela ARDUINI
, Antonio AGOSTINI
, et al.
·
Minerva Urology and Nephrology
·
1
Pattern of disease recurrence and outcomes of localized high-risk renal cell carcinoma (RCC) patients treated with adjuvant (adj) immunotherapy: A single center experience.
2026
·
Denis Occhipinti
, Chiara Ciccarese
, et al.
·
Journal of Clinical Oncology
PDF
Incidence and co-occurrence of targetable key genomic alterations (GenAlt) in metastatic prostate cancer (mPC): Preliminary results from the prostate cancer cohort of the FPG500 program.
2026
·
Daniela Arduini
, Chiara Ciccarese
, et al.
·
Journal of Clinical Oncology
PDF
P297 – The role of circulating kidney injury molecule-1 (KIM-1) in metastatic renal cell carcinoma (mRCC): A biomarker analysis of Tide-A, a phase 2 study of first-line avelumab (ave) plus intermittent axitinib (axi)
2025
·
R.R. Pedone
, A. Agostini
, et al.
·
European Urology
Highlights from the 2024 ASCO Genitourinary Symposium: focus on urothelial and prostate cancer
2024
·
Alessandro Strusi
, Giada Pinterpe
, et al.
·
Expert Review of Anticancer Therapy
Show more works
View as search
Works count:
12
Citation count:
28
H-index:
3
I10-index:
Year
Topic
Type